---
title: "Huachuang Securities Sticks to Its Buy Rating for Jacobio Pharmaceuticals Group Co., Ltd. (1167)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/279156832.md"
description: "Huachuang Securities analyst maintained a Buy rating on Jacobio Pharmaceuticals Group Co., Ltd. yesterday and set a price target of HK$11.65.Claim 70% Off TipRanks PremiumUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Jacobio Pharmaceuticals Group Co., Ltd. with a HK$11.00 average price target."
datetime: "2026-03-15T12:35:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279156832.md)
  - [en](https://longbridge.com/en/news/279156832.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279156832.md)
---

# Huachuang Securities Sticks to Its Buy Rating for Jacobio Pharmaceuticals Group Co., Ltd. (1167)

Huachuang Securities analyst maintained a Buy rating on Jacobio Pharmaceuticals Group Co., Ltd. yesterday and set a price target of HK$11.65.

### Claim 70% Off TipRanks Premium

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Jacobio Pharmaceuticals Group Co., Ltd. with a HK$11.00 average price target.

### Related Stocks

- [562050.CN](https://longbridge.com/en/quote/562050.CN.md)
- [159892.CN](https://longbridge.com/en/quote/159892.CN.md)
- [159570.CN](https://longbridge.com/en/quote/159570.CN.md)
- [513060.CN](https://longbridge.com/en/quote/513060.CN.md)
- [01167.HK](https://longbridge.com/en/quote/01167.HK.md)
- [159316.CN](https://longbridge.com/en/quote/159316.CN.md)
- [159992.CN](https://longbridge.com/en/quote/159992.CN.md)
- [512010.CN](https://longbridge.com/en/quote/512010.CN.md)
- [513700.CN](https://longbridge.com/en/quote/513700.CN.md)
- [516500.CN](https://longbridge.com/en/quote/516500.CN.md)
- [588130.CN](https://longbridge.com/en/quote/588130.CN.md)
- [159849.CN](https://longbridge.com/en/quote/159849.CN.md)
- [520500.CN](https://longbridge.com/en/quote/520500.CN.md)
- [159506.CN](https://longbridge.com/en/quote/159506.CN.md)
- [516930.CN](https://longbridge.com/en/quote/516930.CN.md)
- [159837.CN](https://longbridge.com/en/quote/159837.CN.md)
- [510660.CN](https://longbridge.com/en/quote/510660.CN.md)
- [512290.CN](https://longbridge.com/en/quote/512290.CN.md)
- [513120.CN](https://longbridge.com/en/quote/513120.CN.md)

## Related News & Research

- [Wuxi AppTec to Raise Around $1 Billion Through Zero Coupon Convertible Bonds](https://longbridge.com/en/news/286487023.md)
- [Everest Medicines Director and Major Shareholder Raises Stake in Company](https://longbridge.com/en/news/286481551.md)
- [Analyst Reiterates Buy on Microbix, Citing Temporary China Slowdown and Growing Diversified Demand](https://longbridge.com/en/news/286665358.md)
- [Jacobio Boosts Share Buybacks and Liquidity as Oncology Pipeline Advances](https://longbridge.com/en/news/286835606.md)
- [20:03 ETHarbour BioMed Announces Promising Preclinical Data for LET003, Its First AI-Enabled Drug Candidate](https://longbridge.com/en/news/286688082.md)